Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality—a multicentre prospective cohort study

Abstract

Background Early diagnosis of tuberculosis (TB) is important to reduce transmission, morbidity and mortality in people living with HIV (PLWH). Methods PLWH with a diagnosis of TB were enrolled from HIV and TB clinics in Eastern Europe and followed until 24 months. Delayed diagnosis was defined as duration of TB symptoms (cough, weight-loss or fever) for ≥ 1 month before TB diagnosis. Risk factors for delayed TB diagnosis were assessed using multivariable logistic regression. The effect of delayed diagnosis on mortality was assessed using Kaplan–Meier estimates and Cox models. Findings 480/740 patients (64.9%; 95% CI 61.3–68.3%) experienced a delayed diagnosis. Age ≥ 50 years (vs. < 50 years, aOR = 2.51; 1.18–5.32; p = 0.016), injecting drug use (IDU) (vs. non-IDU aOR = 1.66; 1.21–2.29; p = 0.002), being ART naïve (aOR = 1.77; 1.24–2.54; p = 0.002), disseminated TB (vs. pulmonary TB, aOR = 1.56, 1.10–2.19, p = 0.012), and presenting with weight loss (vs. no weight loss, aOR = 1.63; 1.18–2.24; p = 0.003) were associated with delayed diagnosis. PLWH with a delayed diagnosis were at 36% increased risk of death (hazard ratio = 1.36; 1.04–1.77; p = 0.023, adjusted hazard ratio 1.27; 0.95–1.70; p = 0.103). Conclusion Nearly two thirds of PLWH with TB in Eastern Europe had a delayed TB diagnosis, in particular those of older age, people who inject drugs, ART naïve, with disseminated disease, and presenting with weight loss. Patients with delayed TB diagnosis were subsequently at higher risk of death in unadjusted analysis. There is a need for optimisation of the current TB diagnostic cascade and HIV care in PLWH in Eastern Europe.

Predictors for Pulmonary Tuberculosis Outcome and Adverse Events in an Italian Referral Hospital: A Nine-Year Retrospective Study (2013–2021)

“…In line with European data, in our cohort there is a slight prevalence of male subjects [ 10 11 ] and almost three-quarters of our cohort belonged to the younger group with a median age of 39 years; our study population is younger than would be expected in low TB burden countries in which the geriatric population represents a large reservoir of TB infection [ 12 13 ].…”

The socio-demographic, clinical characteristics and outcomes of tuberculosis among HIV infected adults in Lithuania: A thirteen-year analysis

“…The rate of miliary TB was 12.6% in new TB cases and 6.6% in previously treated TB cases and this form of TB was not associated with the poorer treatment outcome. In other large multicenter prospective studies [ 16 , 56 ], the rate of miliary TB was higher and the association with the increased risk of death was found. These differences could be explained by a larger number of participants and different stratifications used for analysis.…”

“…The assessment of TB treatment outcomes, analysis and prevention of factors associated with unsuccessful treatment results is of crucial importance in reaching the success in TB control programme. In the frame of WHO End TB Strategy [ 56 ], this study identified risk groups requiring integrated programmatic case management.…”

Impact of COVID-19 on the National Tuberculosis Elimination Program in Uttarakhand, India: A Mixed-Methods Research Study

“…TB laboratories and TB wards were re-assigned to the fight against COVID-19, which also disrupted TB services due to late diagnosis and late initiation of treatment. Delayed diagnosis can lead to the worst outcomes and, in the case of communicable diseases like TB, increases the chances of household transmission [ 15 ].…”